NCT00230074
- Conditions
- Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
- Locations
-
- Novartis East Hanover, New Jersey, United States
Clinical trial condition
Amyotrophic Lateral Sclerosis
Explore clinical trials studying Amyotrophic Lateral Sclerosis. Study availability and eligibility vary by location and protocol.
707 public trials
173 recruiting studies
Amyotrophic Lateral Sclerosis trial results
NCT00606918
- Conditions
- Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis & Other Neuromuscular Disorders, Central Nervous System Diseases, +13 more
- Locations
-
- Massachusetts General Hospital - East Charlestown, Massachusetts, United States
NCT00409721
- Conditions
- Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
- Locations
-
- Calgary ALS Neuromuscular Clinic Calgary, Alberta, Canada
- University of Alberta ALS Clinic Edmonton, Alberta, Canada
NCT00355576
- Conditions
- Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +9 more
- Locations
-
- Phoenix Neurological Associates Phoenix, Arizona, United States
- UCLA Los Angeles, California, United States
- University of California Irvine Orange, California, United States
- California Pacific Medical Center San Francisco, California, United States
Completed
Clinical Trial on the Use of Autologous Bone Marrow Stem Cells in Amyotrophic Lateral Sclerosis
NCT00855400
- Conditions
- Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
- Locations
-
- Hospital Universitario Virgen de la Arrixaca El Palmar, Murcia, Spain
NCT01091142
- Conditions
- Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
- Locations
-
- California Pacific Medical Center San Francisco, California, United States
- University of Kansas Medical Center - Landon Center on Aging Kansas City, Kansas, United States
- Department of Neurology; University of Kentucky Medical Center Lexington, Kentucky, United States
Completed
R(+)PPX High Dose Treatment of ALS
NCT00600873
- Conditions
- Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
- Locations
-
- University of Virginia Charlottesville, Virginia, United States
NCT00635960
- Conditions
- Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
- Locations
-
- Diparimento di Scienze Neurologiche Naples, Italy
- Istituto Biostrutture e Bioimmagini, Consiglio Nazionale delle Ricerche Naples, Italy
NCT00302198
- Conditions
- Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
- Locations
-
- Forbes Norris MDA/ALS Center San Francisco, California, United States
Completed
Safety Study of Oral Sodium Phenylbutyrate in Subjects With ALS (Amyotrophic Lateral Sclerosis)
NCT00107770
- Conditions
- Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
- Locations
-
- VA Medical Center, Iowa City Iowa City, Iowa, United States
- VA Medical Center, Lexington Lexington, Kentucky, United States
- VA Maryland Health Care System, Baltimore Baltimore, Maryland, United States
- Edith Nourse Rogers Memorial Veterans Hospital, Bedford Bedford, Massachusetts, United States